Back to top

Researchers from Sant Joan de Déu manage to predict the possible evolution of pediatric sarcomas

This advance may make it possible to identify patients at higher risk of relapse from the time of diagnosis and to better personalise their treatment.

Published in:
6 July 2021
Researchers Helena Castillo and Ángel Montero, of the Institut de Recerca Sant Joan de Déu Barcelona.
Researchers Helena Castillo and Ángel Montero, of the Institut de Recerca Sant Joan de Déu Barcelona.
https://www.sjdhospitalbarcelona.org/sites/default/files/u1/Sala_premsa/Noticias/2021/helena-castillo-angel-montero-institut-recerca-sant-joan-deu.jpg

The research team of the Paediatric Cancer Program of the Institut de Recerca Sant Joan de Déu (IRSJD) and SJd Barcelona Children's Hospital has made public its ten-year experience in the creation of animal models of paediatric sarcomas such as Ewing's sarcoma, rhabdomyosarcoma and osteosarcoma. 

Its aim is to identify possible treatments based on the genetics of the tumour and to characterise the efficacy of different therapeutic strategies in a patient, thus improving the personalisation of treatment.

The project was led by Ángel Montero Carcaboso, head of the Paediatric Cancer Treatment group at the IRSJD. The results of this study, whose first author is Helena Castillo Écija (IRSJD), are on the front cover of the scientific journal The Journal of Pathology Clinical Research.

MORE INFORMATION ON THE IRSJD

 

Hospital Sant Joan de Déu https://www.sjdhospitalbarcelona.org/sites/default/themes/hsjd/logo.svg
Researchers from Sant Joan de Déu manage to predict the possible evolution of pediatric sarcomas